Neuphoria Therapeutics (NEUP) Institutional Ownership $12.31 -0.14 (-1.12%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Neuphoria Therapeutics (NASDAQ:NEUP)CurrentInstitutional OwnershipPercentage15.90%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$57.60KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$13.67K Get NEUP Insider Trade Alerts Want to know when executives and insiders are buying or selling Neuphoria Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Neuphoria Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/4/2025 AdvisorShares Investments LLC67,733$481K0.1%-2.8%3.603% 4/17/2025Cyndeo Wealth Partners LLC10,000$58K0.0%N/A0.569% 2/14/2025Jane Street Group LLC13,311$46K0.0%N/A0.817% 2/14/2025Lynx1 Capital Management LP45,806$157K0.1%N/A2.810% (Data available from 1/1/2016 forward) NEUP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NEUP shares? During the previous two years, the following institutional investors and hedge funds held shares of Neuphoria Therapeutics shares: AdvisorShares Investments LLC ($481K), Lynx1 Capital Management LP ($157K), and Cyndeo Wealth Partners LLC ($58K), Jane Street Group LLC ($46K).Learn more on Neuphoria Therapeutics' institutional investors. What percentage of Neuphoria Therapeutics' stock is owned by institutional investors? 15.90% of Neuphoria Therapeutics' stock is owned by institutional investors. Learn more on NEUP's institutional investor holdings. Which institutional investors have been buying Neuphoria Therapeutics' stock? The following institutional investors have purchased Neuphoria Therapeutics' stock in the last 24 months: Lynx1 Capital Management LP ($45.81K), Jane Street Group LLC ($13.31K), and Cyndeo Wealth Partners LLC ($10K). How much institutional buying is happening at Neuphoria Therapeutics? Institutional investors have bought a total of 69,117 shares in the last 24 months. This purchase volume represents approximately $57.60K in transactions. Which of Neuphoria Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Neuphoria Therapeutics stock in the last 24 months: AdvisorShares Investments LLC ($1.93K). How much institutional selling is happening at Neuphoria Therapeutics? Institutional investors have sold a total of 1,926 shares in the last 24 months. This volume of shares sold represents approximately $13.67K in transactions. Related Companies TCRX Institutional Ownership HLVX Institutional Ownership MEIP Institutional Ownership SAVA Institutional Ownership MGNX Institutional Ownership COYA Institutional Ownership IZTC Institutional Ownership ORMP Institutional Ownership IFRX Institutional Ownership SRZN Institutional Ownership This page (NASDAQ:NEUP) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqOn September 30, 2025, at midnight ET... a groundbreaking emergency order goes into effect, issued directly by...Altimetry | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondMost “hot AI stocks” will vanish — but Weiss Ratings’ system, ranked #1 for accuracy, just flagged 10 AI stock...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuphoria Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuphoria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.